Eradication of Helicobacter Pylori May Be Beneficial in the Management of Chronic Open-angle Glaucoma
Overview
Authors
Affiliations
Background: We have documented a high prevalence of Helicobacter pylori infection in patients with glaucoma.
Objective: To evaluate the effect of H pylori eradication on the 2 most commonly used glaucoma parameters: intraocular pressure and visual field.
Methods: A total of 41 patients with glaucoma and 30 age-matched anemic controls underwent upper gastrointestinal endoscopies and gastric mucosal biopsies to detect the presence of H. pylori infection by histologic analysis and rapid urease test (CLOtest; Delta West, Draper, Utah). Saliva samples were also tested by CLOtest. Serum anti-H pylori-specific IgG was analyzed by enzyme-linked immunosorbent assay. Helicobacter pylori-positive patients received a triple eradication regimen (omeprazole, clarithromycin, and amoxicillin treatment), and all patients were observed for 2 years while remaining under the same antiglaucoma therapy.
Results: Helicobacter pylori was detected in 88% of glaucoma cases and in 47% of controls (P<.001). Helicobacter pylori eradication was successful in 83% of treated patients. At the 2-year clinical end point, glaucoma parameters (mean intraocular pressure and mean visual field parameters) were improved in the subgroup of patients where H. pylori eradication was successful (P<.001 for intraocular pressure; P< or =.01 for visual field parameters), but not in the other patients.
Conclusion: Helicobacter pylori eradication may positively influence glaucoma parameters, suggesting a possible causal link between H pylori and glaucoma.
Fecal microbiota transplantation for glaucoma; a potential emerging treatment strategy.
Ebrahimi R, Farsi Y, Nejadghaderi S Curr Res Microb Sci. 2024; 7:100314.
PMID: 39726974 PMC: 11670420. DOI: 10.1016/j.crmicr.2024.100314.
Zhang Y, Huang Y, Wu Y, Zhang J, Chen W, Xu D Front Genet. 2024; 15:1368915.
PMID: 38854431 PMC: 11157063. DOI: 10.3389/fgene.2024.1368915.
Amini E, Moradi Y BMC Ophthalmol. 2023; 23(1):374.
PMID: 37697285 PMC: 10496366. DOI: 10.1186/s12886-023-03111-z.
The Role of Gut Microbiota in Glaucoma Progression and Other Retinal Diseases.
Chen J, Chen D, Cho K Am J Pathol. 2023; 193(11):1662-1668.
PMID: 37490970 PMC: 10616709. DOI: 10.1016/j.ajpath.2023.06.015.
Controlling the Impact of -Related Hyperhomocysteinemia on Neurodegeneration.
Kountouras J, Doulberis M, Papaefthymiou A, Polyzos S, Zavos C, Kazakos E Medicina (Kaunas). 2023; 59(3).
PMID: 36984505 PMC: 10056452. DOI: 10.3390/medicina59030504.